Filing Flows › Aflac (AFL) › Guidance & outlook
Aflac (AFL) guidance and outlook
Aflac (AFL) gave its guidance on Nov 4, 2026: Net income $146M for FY2026. Aflac's 10-Q filed Nov 5, 2026 makes 15 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $842M | new |
| Net income | FY2026 | $146M | new |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- • significant valuation judgments in determination of expected credit losses recorded on the Company's investments
- The Company’s operating expenses primarily consist of insurance benefits provided and reserves established for anticipated future insurance benefits, general business expenses, commissions and other costs of selling and servicing its products.
- This investment strategy incorporates asset-liability matching to align the expected cash flows of the portfolio to the needs of the Company's liability structure.
- Although the Company is unable to predict the timing or extent of future movements of the yen/dollar exchange rate, the Company maintains hedging strategies (see the Hedging Activities section of this MD&A) that are intended to mitigate the impacts of Japanese yen fluctuation on the Company’s financial position and results of operations.
- GAAP guidance for segment reporting, pretax adjusted earnings is the Company's U.S.
- For the full year of 2026, the Company now expects Aflac Japan to generate a benefit ratio slightly below the range of 60% to 63%.
- With continued cost pressure on Japan’s health care system, the Company expects the need for third sector products will continue to rise in the future and that the cancer and medical insurance products Aflac Japan provides will continue to be an important part of its product portfolio.
- For the full year of 2026, the Company now expects Aflac U.S. to generate a benefit ratio below the range of 48% to 52%.
- The Company targets and actively manages liquidity, capital and leverage in the context of a number of considerations, including:
- Further, the Company plans to continue to maintain a population of unhedged U.S. dollar-denominated investments at Aflac Japan and to consider whether the amount of such investments should be increased or decreased relative to the Company’s view of economic equity surplus in Aflac Japan in light of potentially rising hedge costs and other factors.
- The Company believes outside sources for additional debt and equity capital, if needed, will continue to be available.
- Additionally, subject to market conditions, the Company expects that it could take action to enter into derivatives on unhedged U.S. dollar-denominated investments with foreign currency options or forwards or execute additional reinsurance transactions.
Aflac's latest quarter
Aflac, Q3 2026: revenue $3.3B (-31% year over year), operating margin 15.3%, net earnings $303M, operating cash flow $1.2B. The chart follows the revenue to costs, profit and cash.
Questions
Did Aflac raise or lower its guidance?
Aflac (AFL) gave its guidance on Nov 4, 2026: Net income $146M for FY2026.
What does Aflac expect?
• significant valuation judgments in determination of expected credit losses recorded on the Company's investments The Company’s operating expenses primarily consist of insurance benefits provided and reserves established for anticipated future insurance benefits, general business expenses, commissions and other costs of selling and servicing its products. This investment strategy incorporates asset-liability matching to align the expected cash flows of the portfolio to the needs of the Company's liability structure.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.